HMGB1 and breast cancer: The potential of the attenuation of the HMGB1-RAGE-dependent PI3K/AKT pathway in mediating PD-L1 expression is proposed to both inhibit HMGB1-induced breast cancer aggressiveness and T cell function attenuation (Fig. 5c).